Excess Weight, Obesity, Diabetes and Coronavirus Disease Volume 3 - Issue 1

Gundu H R Rao*

• Director, Laboratory Medicine and Pathology, Thrombosis Research, Lillehei Heart Institute, University of Minnesota, USA

Received: September 15, 2020   Published: September 28, 2020

Corresponding author: Gundu H R Rao, Director, Laboratory Medicine and Pathology, Thrombosis Research, Lillehei Heart Institute, University of Minnesota, USA

DOI: 10.32474/ADO.2020.03.000152

Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

SARS-CoV-2 virus has created an unprecedented public health and global economic crisis. Despite the fact, that this virus was discovered half a century ago, earlier version of this RNA virus (SARS-CoV) was less virulent than the 2019 version of the virus (CoV-2), which turned out to be the most potent killer virus. According to the Johns Hopkins University (JHU) Coronavirus Resources Center (coronavirus.jhu.edu), globally there are 28 million Covid-19 infected individuals and 900,000 deaths. In the USA, we have over 6.4 million infected individuals and 192,000 confirmed covid-related deaths.

Introduction| References|